It mainly deals with molecular nanotechnology, nanosensors, nano particles, nanodrugs, drug delivery, nanomaterials, nanobiotechnology, nanobiopharmaceutics, nanoelectronics, nano-devices, nanorobotics.
Nanodrug delivery have been designed to overcome these challenges due to the development and fabrication of nanostructures. It has been reported that, nanostructures have the ability to protect drugs from the degradation in the gastrointestinal tract, the technology also allows target delivery of drugs to various areas of the body. The technology enables the delivery of drugs that are poorly water soluble and can provide means of bypassing the liver, thereby preventing the first pass metabolism. Nanotechnology increases oral bioavailability of drugs due to their specialized uptake mechanisms such as absorptive endocytosis and are able to remain in the blood circulation for a longer time, releasing the incorporated drug in a controlled fashion leading to less plasma fluctuations and minimizing side-effects.
OMICS Group is one of the top open access publishers with 700+ peer-reviewed journals along with eminent scientists in its Editorial Board and expert reviewers to carry rigorous peer-review process. The peer review process is highly appreciated by researchers globally. Editorial Board Members and Reviewers actively participate in the review process within 21 days and ensure the quality of the manuscripts. In addition to open-access publishing, OMICS also provides E-books, Scholar Central and more than 3000+ International Scientific Conferences under its umbrella.
Last date updated on April, 2021